Evaluation of Some Liver Enzymes in HIV/AIDS Patients on Antiretroviral Therapy in University of Abuja Teaching Hospital, Nigeria

Authors

  • Abriba Simon Peter Department of Medical Laboratory Science, Faculty of Allied Health Sciences, Bingham University, Karu Nassarawa State, Nigeria
  • Gambe Solomom Matthias Department of Medical Laboratory Science, Faculty of Allied Health Sciences, Bingham University, Karu Nassarawa State, Nigeria
  • Chindo Ezekiel Department of Medical Laboratory Science, Faculty of Allied Health Sciences, Bingham University, Karu Nassarawa State, Nigeria
  • Osadolor Humphrey Benedo Department of Medical Laboratory Science, College of Health Sciences, University of Benin, Nigeria

DOI:

https://doi.org/10.31344/ijhhs.v8i2.632

Keywords:

HIV/AIDS, antiretroviral therapy, hepatotoxicity, liver enzymes

Abstract

Background: Hepatoxicity is a major complication and side effect of antiretroviral therapy (ART). Unfortunately, such studies in this area of evaluating the adverse drug reaction of ART on the liver hepatocytes are only few in number in Nigeria.

Objective: To determine the levels of some liver enzymes in HIV/AIDS patients on antiretroviral therapy (ART) and as well evaluate their impact on liver hepatocytes.

Methods: This is a hospital-based case-control study. A total of 153 subjects were recruited in the study, and they were divided into three groups: the control group (which consist of apparently healthy subjects), the study group 1 (consist of HIV positive subject not on ART), and study group 2 (consist of HIV/AIDS patients on ART). The liver enzymes Alanine amino Transferase (ALT), Asparate amino Transfarase (AST) and Alkaline Phosphatase (ALP) were determined using enzyme linked spectrophotometric assay methods, according to the manufacturer’s specifications.

Results: The mean standard deviation (SD) of ALT and AST activity of the study group 1 showed significant differences when compared with that of the control group P<0.001, but the ALP has no significant differences P>0.05. In Study group 2, (HIV/AIDS patients on ART) showed significant differences of P<0.001 in ALT, AST and ALP.

Conclusion: Some liver enzymes were elevated in subjects on antiretroviral therapy; this elevation could be due to hepatotoxicity of the (ART) used by the HIV/AIDS patients on the liver hepatocytes.

International Journal of Human and Health Sciences Vol. 08 No. 02 Apr’24 Page: 126-131

Downloads

Published

2024-05-12

How to Cite

Peter, A. S., Matthias, G. S., Ezekiel, C., & Benedo, O. H. (2024). Evaluation of Some Liver Enzymes in HIV/AIDS Patients on Antiretroviral Therapy in University of Abuja Teaching Hospital, Nigeria. International Journal of Human and Health Sciences (IJHHS), 8(2), 126–131. https://doi.org/10.31344/ijhhs.v8i2.632

Issue

Vol. 8 No. 2 (2024)

Section

Original Articles

License

Copyright (c) 2024 Abriba Simon Peter, Gambe Solomom Matthias, Chindo Ezekiel, Osadolor Humphrey Benedo

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish in the International Journal of Human and Health Sciences agree to the following terms that:

  1. Authors retain copyright and grant International Journal of Human and Health Sciences the right of first publication of the work.

  2. Creative Commons Licence
    Articles in International Journal of Human and Health Sciences are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.